Proteomics of Alzheimer's disease: understanding mechanisms and seeking biomarkers.
about
Proteomics of protein post-translational modifications implicated in neurodegenerationBlood-based biomarkers of Alzheimer's disease: challenging but feasibleMass spectrometry as a tool for studying autism spectrum disorder.Inflammatory proteins in plasma are associated with severity of Alzheimer's disease.Label-free quantitative LC-MS proteomics of Alzheimer's disease and normally aged human brains.Alzheimer's disease biomarker discovery using in silico literature mining and clinical validation.Targeted human cerebrospinal fluid proteomics for the validation of multiple Alzheimer's disease biomarker candidatesIdentification of learning-induced changes in protein networks in the hippocampi of a mouse model of Alzheimer's disease.Glycoproteomic analysis of plasma from patients with atopic dermatitis: CD5L and ApoE as potential biomarkers.Alzheimer's Disease, Diagnosis and the Need for Biomarkers.Commonalities in the genetics of Alzheimer's disease and Parkinson's disease.Role of proteomics in biomarker discovery and psychiatric disorders: current status, potentials, limitations and future challenges.The Emerging Role of Proteomics in Precision Medicine: Applications in Neurodegenerative Diseases and Neurotrauma.The Role of Wnt/β-Catenin Signaling Pathway in Disrupted Hippocampal Neurogenesis of Temporal Lobe Epilepsy: A Potential Therapeutic Target?Clusterin associates specifically with Aβ40 in Alzheimer's disease brain tissue.l-Carnitine Modulates Epileptic Seizures in Pentylenetetrazole-Kindled Rats via Suppression of Apoptosis and Autophagy and Upregulation of Hsp70.Identification of prefrontal cortex protein alterations in Alzheimer's disease.
P2860
Q28088631-CDAFB110-94DA-4DF5-AAFC-0261307683D6Q33824444-B0E798AC-2B07-406D-B846-28EE86F27E0EQ34470350-1A3B8AA3-AD22-4C31-9BBE-DD531463AE88Q34769550-CA7877A8-8A3C-4930-9A43-6728A96435A5Q36243522-513B1EB2-97DD-4CCC-AEF3-069283FF5A00Q36430448-111411ED-3931-4ECE-BB2E-468E718A99D0Q37010140-712A313B-88ED-4F35-8EDC-B1668F5481DAQ37144985-B392FEF2-7541-410B-B26C-ADC3D711B643Q37185022-803A59F8-43BA-449C-802D-2E3833472BE3Q37207324-CC71C1DB-5378-4C42-8CBE-ABB99F73B63AQ37352061-A9EF4FC6-2300-4173-9E99-DF59B4C5DCCAQ38027217-F4E88AE6-E342-46D9-B723-B065984FF25DQ38368569-5FAD3C36-4940-4369-AFD1-11D3CD5730F5Q38503188-F58770A5-C55D-4186-BCB4-412C41F6C3ABQ48114506-9366E199-8C76-4A74-9148-08B2FE3C7E14Q51740299-EC2E0ECC-92E9-4EBF-B106-914D7D460E9DQ51763033-F49E6877-B1C8-481D-B192-7A9B49A84148
P2860
Proteomics of Alzheimer's disease: understanding mechanisms and seeking biomarkers.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Proteomics of Alzheimer's disease: understanding mechanisms and seeking biomarkers.
@en
type
label
Proteomics of Alzheimer's disease: understanding mechanisms and seeking biomarkers.
@en
prefLabel
Proteomics of Alzheimer's disease: understanding mechanisms and seeking biomarkers.
@en
P2860
P50
P356
P1476
Proteomics of Alzheimer's disease: understanding mechanisms and seeking biomarkers.
@en
P2093
Andreas Güntert
P2860
P304
P356
10.1586/14789450.4.2.227
P577
2007-04-01T00:00:00Z